Effect of L-NAME-induced hypertension on melatonin receptors and melatonin levels in the pineal gland and the peripheral organs of rats

Hypertension Research

Volumn 32, Issue 4, 2009, Pages 242-247

  Benova, Miroslava ^a   Herichova, Iveta ^a   Stebelova, Katarina ^a   Paulis, Ludovit ^b,c   Krajcirovicova, Kristina ^b   Simko, Fedor ^b   Zeman, Michal ^a  

^a Physics and Informatics   (Slovakia)

^b Bratislava   (Slovakia)

^c INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Aorta; Blood pressure; Melatonin receptors

Indexed keywords

MELATONIN; MELATONIN 1 RECEPTOR; N(G) NITROARGININE METHYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CIRCADIAN RHYTHM; CONTROLLED STUDY; HEART; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE SYNTHESIS; HYPERTENSION; KIDNEY PARENCHYMA; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PINEAL BODY; RAT; RECEPTOR DENSITY;

ANIMALS; AORTA; BLOTTING, WESTERN; CIRCADIAN RHYTHM; ENZYME INHIBITORS; HYPERTENSION; KIDNEY; LIGHT; MALE; MELATONIN; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PINEAL GLAND; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; RECEPTORS, MELATONIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77952315867     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.12     Document Type: Article

References (41)

1. Zanoboni A, Forni A, Zanoboni-Muciaccia W, Zanussi C. Effect of pinealectomy on arterial blood pressure and food and water intake in the rat. J Endocrinol Invest 1978; 1: 125-130. (Pubitemid 9100769)
2. Holmes SW, Sugden D. The effect of melatonin on pinealectomy-induced hypertension in the rat. Br J Pharmacol 1976; 56: 360-361.
3. Scheer FA, Van Montfrans GA, van Someren EJ, Mairuhu G, Buijs RM, Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension 2004; 43: 192-197. (Pubitemid 38174173)
4. Grossman E, Laudon M, Yalcin R. Zengil H, Peleg E, Sharabi Y, Kamari Y, Shen-Orr Z, Zisapel N. Melatonin reduces night blood pressure in patients with nocturnal hypertension. Am J Med 2006; 119: 898-902. (Pubitemid 44415610)
5. Chuang JI, Chen SS, Lin MT, Melatonin decreases brain serotonin release, arterial pressure and heart rate in rats. Pharmacology 1993; 47: 91-97.
6. Jonas M, Garfinkel D, Zisapel N, Laudon M, Grossman E. Impaired nocturnal melatonin secretion in non-dipper hypertensive patients, Blood Press 2003; 12: 19-24. (Pubitemid 36416949)
7. Zeman M, Dulkova K, Bada V, Herichova I, Plasma melatonin concentrations in hypertensive patients with the dipping and non-dipping blood pressure profile. Life Sci 2005; 76: 1795-1803. (Pubitemid 40215221)
8. Escames G, Khaldy H, León J, González L, Acuña-Castroviejo D. Changes in iNOS activity, oxidative stress and melatonin levels in hypertensive patients treated with lacidipine. J Hypertens 2004; 22: 629-635. (Pubitemid 38368498)
9. Dubocovich ML, Rivera-Bermudez MA, Gerdin MJ, Masana MI, Molecular pharmacology, regulation and function of mammalian melatonin receptors, Front Biosci 2003; 8: 1093-1108.
10. Reppert SM, Weaver DM, Godson C. Melatonin receptors step into the light: cloning and classification of subtypes, Trends Pharmacol Sci 1996; 17: 100-102. (Pubitemid 26111451)
11. Sallinen P, Mänttäri S, Leskinen H, lives M, Vakkuri O, Ruskoaho H, Saarela S. The effect of myocardial infarction on the synthesis, concentration and receptor expression of endogenous melatonin, J Pineal Res 2007; 42: 254-260.
12. Ekmekcioglu C, Thalhammer T, Humpeler S, Mehrabi MR, Glogar HD, Hölzenbein T, Markovic O, Leibetseder VJ, Strauss-Blasche G, Marktl W. The melatonin receptor subtype MT2 Is present in the human cardiovascular system, J Pineal Res 2003; 35: 40-44. (Pubitemid 36819169)
13. Savaskan E, Olivieri G, Brydon L, Jockers R, Kräuchi K, Wirz-Justice A, Müller-Spahn F. Cerebrovascular melatonin MT1-receptor alterations in patients with Alzheimer's disease. Neurosci Lett 2001; 308: 9-12. (Pubitemid 32607668)
14. Masana MI, Doolen S, Ersahin C, Al-Ghoul WM, Duckles SP, Dubocovich ML, Krause DN. MT2 melatonin receptor are represent and functional in rat caudal artery, J Pharmacol Exp Ther 2002; 302: 1295-1302. (Pubitemid 34920255)
15. Ekmekcioglu C, Haslmayer P, Philipp C, Mehrabi MR, Glogar HD, Grimm M, Thalhammer T, Marktl W. 24 h variation in the expression of the mtl melatonin receptor subtype in coronary arteries derived from patients with coronary heart disease. Chronobiol Int 2001; 18: 973-985. (Pubitemid 34020045)
16. Viswanathan M, Laitinen JT, Saavedra JM, Expression of melatonin receptors in arteries involved in thermoregulation, Proc Natl Acad Sci USA 1990; 87: 6200-6203. (Pubitemid 120030268)
17. Doolen S, Krause DN, Dubocovich ML, Duckies SP, Melatonin mediates two distinct responses in vascular smooth muscle, Eur J Pharmacol 1998; 345: 67-69. (Pubitemid 28179472)
18. Zeman M, Nosalova V, Bobek P, Zakalova M. Changes of endogenous melatonin and protective effect of diet containing pleuran and extract of black elder in colonic inflammation in rats. Biologia 2001; 56: 691-697. (Pubitemid 33689938)
19. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
20. Klemfuss H, Clopton PL. Seeking tau: a comparison of six methods, J Interdiscipl Cycle Res 1993; 24: 1-16.
21. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein Is nitric oxide. Proc Natl Acad Sci USA 1987; 84: 9265-9269.
22. Pechanova O, Bernatova I, Effect of long-term NO synthase inhibition on cyclic nucleotide content in rat tissues. Physiol Res 1996; 45: 305-309. (Pubitemid 26315565)
23. Paulis L, Zicha J, Kunes J, Hojna S, Behuliak M, Celec P, Kojsova S, Pechanova O, Simko F. Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor. Hypertens Res 2008; 31: 793-803. (Pubitemid 351772871)
24. Deniz E, Sahna E, Aksulu HE, Nitric oxide synthase inhibition in rats: melatonin reduces blood pressure and ischemia/reperfusion-induced infarct size. Scand Cardiovase J 2006; 40: 248-252. (Pubitemid 44241467)
25. Paulis L, Pechanova O, Zicha J, Gardlik R, Celec P, Kunes J, Simko F. The effect of melatonin on vascular function in L-NAME-induced hypertension, J Mol Cell Cardiol 2008; 44: 811, abstract - full text under submission).
26. Pechanova O, Zicha J, Paulis L, Zenebe W, Dobesová Z, Kojsová S, Jendeková L, Sládková M, Dovinová I, Simko F, Kunes J, The effect of N-acetylcysteine and melatonin in adult spontaneously hypertensive rats with established hypertension. Eur J Pharmacol 2007; 561: 129-136. (Pubitemid 46435853)
27. Paulis L, Simko F. Blood pressure modulation and cardiovascular protection by melatonin: potential mechanisms behind. Physiol Res 2007; 56: 671-684.
28. Simko F, Paulis L. Melatonin as a potential antihypertensive treatment, J Pineal Res 2007; 42: 319-322.
29. Rossi DJ, Hamann M, Attwell D, Multiple modes of GABAergic inhibition of rat cerebellar granule cells. J Physiol 2003; 548: 97-110. (Pubitemid 36410800)
30. Schenda J, Vollrath L. Nitric oxide inhibits electrically active units in the pineal gland. J Neural Transm 1997; 104: 53-58. (Pubitemid 27073228)
31. Moore RY. Neural control of the pineal gland. Behav Brain Res 1996; 73: 125-130.
32. White BH, Sidhu A. Increased oxidative stress in renal proximal tubules of the spontaneously hypertensive rat: a mechanism for defective dopamine D1A receptor/ G-protein coupling, J Hypertens 1998; 16: 1659-1665. (Pubitemid 28515493)
33. Leibowitz A, Peleg E, Sharabi Y, ShabtaI Z, ShamIss A, Grossman E. The role of melatonin in the pathogenesis of hypertension in rats with metabolic syndrome, Am J Hypertens 2008; 21: 348-351. (Pubitemid 351323274)
34. Reiter RJ, Tan DX, Qi WB. Suppression of oxygen toxicity by melatonin, Zhongguo Yao Li Xue Bao 1998; 19: 575-581.
35. Jendekova L, Kojsova S, Andriantsitohaina R, Pechanova O, The time-dependent effect of Provinols on brain NO synthase activity in L-NAME-induced hypertension. Physiol Res 2006; 55: S31-S37. (Pubitemid 47535210)
36. Rauchova H, Pechanova O, Kunes J, Vokurkova M, Dobesova Z, Zicha J, Chronic N-acetylcysteine administration prevents development of hypertension in N(omega)-nitro-L-arginine methyl ester-treated rats: the role of reactive oxygen species. Hypertens Res 2005; 28: 475-482. (Pubitemid 41007463)
37. Nava M, Quiroz Y, Vaziri N, Rodriguez-Iturbe B, Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats. Am J Physiol Renal Physiol 2003; 284: F447-F454. (Pubitemid 36227905)
38. Paulis L, Krajcirovicova K, Janega P, Kojsova S, Csizmadiova Z. Pechanova O, Simko F. The antihypertensive action of melatonin in spontaneously hypertensive rats: comparison with spironolactone, Hypertension 2006; 48: 776.
39. Stebelova K, Herichova I, Zeman M. Diabetes induces changes in melatonin concentrations in peripheral tissues of rat. Neuro Endocrinol Lett 2007; 28: 159-165. (Pubitemid 46744781)
40. Tengattini S, Reiter RJ, Tan DX, Terron MP, Rodella LF, Rezzani R. Cardiovascular diseases: protective effects of melatonin, J Pineal Res 2008; 44: 16-25. (Pubitemid 350231106)
41. Fitch RM, Vergona R, Sullivan ME, Wang YX. Nitric oxide synthase inhibition increases aortic stiffness measured by pulse wave velocity in rats. Cardiovasc Res 2001; 51: 351-358, (Pubitemid 32695546)